MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Masimo Corporation Operating Expenses 2011-2026 | MASI
Annual Operating Expenses Masimo Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.27 B | 867 M | 849 M | 487 M | - | 408 M | 367 M | 338 M | 290 M | 287 M | - | 279 M | 241 M | 179 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 B | 179 M | 489 M |
Quarterly Operating Expenses Masimo Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 147 M | 169 M | 156 M | - | 174 M | 165 M | 154 M | - | 192 M | 247 M | - | - | 236 M | 145 M | - | 136 M | 128 M | 131 M | - | 119 M | 129 M | 117 M | - | 105 M | 102 M | 95.6 M | - | 92.1 M | 90.5 M | 89.8 M | - | 81 M | 83.1 M | 80.3 M | - | 73.5 M | 78.7 M | 76.9 M | - | 74.1 M | 75.1 M | 75.7 M | - | 74 M | 74.7 M | 62.1 M | - | 66.7 M | 68.1 M | 66.4 M | - | 60.4 M | 58.8 M | 57 M | - | 49.5 M | 53.1 M | 51.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 247 M | 49.5 M | 106 M |
Operating Expenses of other stocks in the Medical instruments industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
3.88 B | $ 19.92 | 0.94 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
27 M | $ 5.36 | -1.65 % | $ 244 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
OraSure Technologies
OSUR
|
108 M | $ 2.74 | -1.79 % | $ 204 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
20 M | $ 8.65 | 3.1 % | $ 174 M | USA |
 |
Alcon
ALC
|
3.37 B | $ 80.83 | -0.37 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
388 M | $ 36.3 | -1.76 % | $ 1.7 B | USA |
 |
Haemonetics Corporation
HAE
|
527 M | $ 65.68 | -0.42 % | $ 3.31 B | USA |
 |
electroCore
ECOR
|
32.5 M | $ 6.88 | -3.1 % | $ 37.9 K | USA |
 |
AngioDynamics
ANGO
|
198 M | $ 10.13 | 1.5 % | $ 414 M | USA |
 |
ICU Medical
ICUI
|
782 M | $ 149.56 | -0.31 % | $ 3.65 B | USA |
 |
InfuSystem Holdings
INFU
|
60.9 M | $ 8.1 | 0.56 % | $ 167 M | USA |
 |
STERIS plc
STE
|
1.54 B | $ 260.7 | -0.36 % | $ 25.7 B | USA |
 |
The Cooper Companies
COO
|
1.23 B | $ 80.7 | 0.41 % | $ 16.1 B | USA |
 |
Harvard Bioscience
HBIO
|
64.2 M | $ 0.49 | -8.67 % | $ 20.8 M | USA |
 |
Glaukos Corporation
GKOS
|
368 M | $ 117.26 | -1.52 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
488 M | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
Isoray
ISR
|
92.3 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
523 M | $ 148.9 | -0.06 % | $ 4.65 B | USA |
 |
LeMaitre Vascular
LMAT
|
98.6 M | $ 84.46 | 0.72 % | $ 1.9 B | USA |
 |
Intuitive Surgical
ISRG
|
3.29 B | $ 503.83 | -0.73 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 60.61 | -1.69 % | $ 220 M | USA |
 |
Microbot Medical
MBOT
|
9.09 K | $ 1.82 | -2.15 % | $ 18.6 M |  Israel |
 |
Nephros
NEPH
|
10 M | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Milestone Scientific
MLSS
|
13.2 M | $ 0.3 | -1.38 % | $ 23.9 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.27 B | $ 23.08 | -1.33 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
8.82 M | $ 37.95 | -3.69 % | $ 125 M | USA |
 |
Predictive Oncology
POAI
|
11.7 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 13.88 | 1.91 % | $ 667 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.05 B | $ 201.3 | 0.11 % | $ 57.9 B | USA |
 |
Repligen Corporation
RGEN
|
115 M | $ 152.02 | -2.78 % | $ 8.47 M | USA |
 |
ResMed
RMD
|
1.02 B | $ 250.46 | -2.78 % | $ 36.6 B | USA |
 |
BioLife Solutions
BLFS
|
17.8 M | $ 21.94 | -2.85 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
36.7 M | $ 2.24 | -3.86 % | $ 181 M | USA |
 |
Retractable Technologies
RVP
|
20.1 M | $ 0.69 | -2.01 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 18.74 | -1.06 % | $ 921 M | USA |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 105.09 | -0.37 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
301 M | $ 225.53 | -3.06 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 12.32 | 0.37 % | $ 2.5 B | USA |